Growth through expansion Seppic is expanding its portfolio with new offerings in companion animal vaccines and mature skin solutions, signaling opportunities to cross-sell cosmetic, nutraceutical, and veterinary ingredient capabilities to existing and new clients in high-growth segments.

Strategic partnerships The collaboration with LCS Biotech and ongoing partnerships indicate openness to co-develop or source advanced bioactive lipids, enabling a sales approach focused on premium formulations and differentiated actives for cosmetics and nutraceuticals.

Leadership transition A new CEO appointed in September 2026 may drive strategic realignment, offering a window to engage with top management on long-term supply agreements, sustainability initiatives, and innovation roadmaps that align with customer needs.

Awards and credibility Recent recognition for functional ingredients and innovative polymers enhances market credibility, creating decision-maker leverage for proposals emphasizing performance, regulatory readiness, and patented or award-winning technologies.

Digital and tech readiness Adoption of modern tech stack and proximity to digital platforms suggests efficient collaboration potential for rapid onboarding, integrated supply chain solutions, and customer portals for streamlined order management and technical support.